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Rehabilitation of sensory and/or motor functions in patients with neurological diseases is 
more and more dealing with artificial electrical stimulation and recording from populations of 
neurons using biocompatible chronic implants. As more and more patients have benefited 
from these approaches, the interest in neural interfaces has grown significantly. However an 
important problem reported with all available microelectrodes to date is long-term viability 
and biocompatibility. Therefore it is essential to understand the signals that lead to neuroglial 
activation and create a targeted intervention to control the response, reduce the adverse nature 
of the reactions and maintain an ideal environment for the brain-electrode interface. We discuss 
some of the exciting opportunities and challenges that lie in this intersection of neuroscience 
research, bioengineering, neurology and biomaterials.
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Figure 1 | Development of glial encapsulation on an intracortical 
microelectrode. (A) Acute neural injury caused by inserting a microelectrode 
into the brain cortex. Astrocytes and microglial cells become activated and 
migrate to the site of injury. (B) Chronic response showing a dense sheath 
around implanted probes, which contains fibroblasts, macrophages and 
astrocytes. (C,D) The reactive astrocytes, immunohistochemically labeled here 
for GFAP , encapsulate the neural probes forming a dense cellular sheath. 
Calibration bar = 50 μm.Frontiers in Neuroengineering  www.frontiersin.org  May 2010  | Volume 3  | Article 8  |  3




























































































Figure 2 | Photomicrograph showing astrocytes (gFAP staining, red) 
and neurons (NeuN staining, green) around one microelectrode track 
(asterisk) following chronic implantation of a NeuroProbes 
multielectrode array in rabbit occipital cortex. Calibration bar = 50 μm.Frontiers in Neuroengineering  www.frontiersin.org  May 2010  | Volume 3  | Article 8  |  4
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(2)	 Improve	 long-term	 biocompatibility	 and	 re-engineer	 the	
brain’s	response	to	the	insertion	of	microelectrodes	through	






















Figure 3 | Summary of optimum surface behavior for an implanted 
neural probe. (A) Surface of encapsulation and insulation material: adsorption 
of proteins and adhesion of fibroblast for good incorporation into the tissue, no 
reaction of macrophages. (B) Surface without electrodes: good contact to 
neurons and glial cells, no reaction of macrophages. (C) Surface of electrodes: 
attraction and good contact to neurons, no adhesion of fibroblasts, no 
macrophage reaction.Frontiers in Neuroengineering  www.frontiersin.org  May 2010  | Volume 3  | Article 8  |  5
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